PT3996699T - Combinação de ibuprofeno e tramadol para aliviar a dor - Google Patents

Combinação de ibuprofeno e tramadol para aliviar a dor

Info

Publication number
PT3996699T
PT3996699T PT207402660T PT20740266T PT3996699T PT 3996699 T PT3996699 T PT 3996699T PT 207402660 T PT207402660 T PT 207402660T PT 20740266 T PT20740266 T PT 20740266T PT 3996699 T PT3996699 T PT 3996699T
Authority
PT
Portugal
Prior art keywords
tramadol
ibuprofen
combination
relieve pain
relieve
Prior art date
Application number
PT207402660T
Other languages
English (en)
Portuguese (pt)
Original Assignee
Farmalider Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmalider Sa filed Critical Farmalider Sa
Publication of PT3996699T publication Critical patent/PT3996699T/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
PT207402660T 2019-07-09 2020-07-08 Combinação de ibuprofeno e tramadol para aliviar a dor PT3996699T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP19382583 2019-07-09

Publications (1)

Publication Number Publication Date
PT3996699T true PT3996699T (pt) 2023-07-27

Family

ID=67480112

Family Applications (1)

Application Number Title Priority Date Filing Date
PT207402660T PT3996699T (pt) 2019-07-09 2020-07-08 Combinação de ibuprofeno e tramadol para aliviar a dor

Country Status (21)

Country Link
US (1) US12514833B2 (cg-RX-API-DMAC7.html)
EP (1) EP3996699B1 (cg-RX-API-DMAC7.html)
JP (1) JP7656339B2 (cg-RX-API-DMAC7.html)
CN (1) CN114080221B (cg-RX-API-DMAC7.html)
AU (1) AU2020309160B2 (cg-RX-API-DMAC7.html)
BR (1) BR112022000242A2 (cg-RX-API-DMAC7.html)
CA (1) CA3145632C (cg-RX-API-DMAC7.html)
DK (1) DK3996699T3 (cg-RX-API-DMAC7.html)
ES (1) ES2952013T3 (cg-RX-API-DMAC7.html)
FI (1) FI3996699T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20230677T1 (cg-RX-API-DMAC7.html)
HU (1) HUE062529T2 (cg-RX-API-DMAC7.html)
MA (1) MA56341B1 (cg-RX-API-DMAC7.html)
MD (1) MD3996699T2 (cg-RX-API-DMAC7.html)
MX (1) MX2022000373A (cg-RX-API-DMAC7.html)
MY (1) MY207573A (cg-RX-API-DMAC7.html)
PL (1) PL3996699T3 (cg-RX-API-DMAC7.html)
PT (1) PT3996699T (cg-RX-API-DMAC7.html)
RS (1) RS64500B1 (cg-RX-API-DMAC7.html)
SI (1) SI3996699T1 (cg-RX-API-DMAC7.html)
WO (1) WO2021005129A1 (cg-RX-API-DMAC7.html)

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB971700A (en) 1961-02-02 1964-09-30 Boots Pure Drug Co Ltd Anti-Inflammatory Agents
US3652589A (en) 1967-07-27 1972-03-28 Gruenenthal Chemie 1-(m-substituted phenyl)-2-aminomethyl cyclohexanols
GB1497044A (en) 1974-03-07 1978-01-05 Prodotti Antibiotici Spa Salts of phenyl-alkanoic acids
AU661723B2 (en) 1991-10-30 1995-08-03 Mcneilab, Inc. Composition comprising a tramadol material and a non-steroidal anti-inflammatory drug
US5516803A (en) * 1991-10-30 1996-05-14 Mcneilab, Inc. Composition comprising a tramadol material and a non-steroidal anti-inflammatory drug
IT1264855B1 (it) 1993-06-21 1996-10-17 Zambon Spa Composizioni farmaceutiche contenenti sali dell'acido s(+)-2-(4-isobutilfenil) propionico con amminoacidi basici
IT1264857B1 (it) 1993-06-21 1996-10-17 Zambon Spa Composizione farmaceutica liquida per uso orale contenente acido 2-(4-isobutilfenil) propionico
US6348216B1 (en) 1996-06-10 2002-02-19 Knoll Pharmaceutical Company Ibuprofen and narcotic analgesic compositions
WO2000025769A1 (en) 1998-11-02 2000-05-11 Ortho-Mcneil Pharmaceutical, Inc. Analgesic regimen
US6251945B1 (en) 1999-01-14 2001-06-26 Knoll Aktiengesellschaft Pharmaceutical mixture comprising a combination of a profen and other active compounds
US6211246B1 (en) 1999-06-10 2001-04-03 Mcneil-Ppc, Inc. Rapidly absorbed liquid compositions
US6342530B1 (en) 2000-11-14 2002-01-29 Farmacon-Il, Llc Composition and method for parenteral administration of ibuprofen d,l- or l-lysine salt
US6727286B2 (en) 2001-11-02 2004-04-27 Cumberland Pharmaceuticals Inc. Pharmaceutical composition of 2-(4-isobutylphenyl) propionic acid
JP5185488B2 (ja) 2001-11-02 2013-04-17 カンバーランド ファーマシューティカルズ,インコーポレーテッド 2−(4−イソブチルフェニル)プロピオン酸の医薬組成物
EP1558234B1 (en) 2002-10-25 2007-05-23 Dompé S.P.A. Painless injectable compositions containing salt of 2-arylpropionic acids
US20070117826A1 (en) * 2005-11-23 2007-05-24 Forest Laboratories, Inc. Pharmaceutical formulations comprising ibuprofen, oxycodone, and 14-hydroxycodeinone
EP2149546A1 (en) * 2008-07-31 2010-02-03 Laboratorios Del. Dr. Esteve, S.A. Salts of tramadol and ibuprofen and their crystal form in the treatment of pain
EP2381937A2 (en) 2008-12-31 2011-11-02 Upsher-Smith Laboratories, Inc. Opioid-containing oral pharmaceutical compositions and methods
AU2010224063B2 (en) 2009-03-12 2015-04-16 Cumberland Pharmaceuticals Inc Administration of intravenous ibuprofen
US8871810B2 (en) 2009-07-15 2014-10-28 Cumberland Pharmaceuticals Inc. Treating critically ill patients with intravenous ibuprofen
US8735452B2 (en) 2009-07-15 2014-05-27 Cumberland Pharmaceuticals Inc. Treating patients with intravenous ibuprofen
ES2356762B1 (es) * 2009-09-04 2011-11-24 Farmalider S.A. Composicion farmaceutica de ibuprofeno, tramadol y un aminoacido basico, procedimiento para su preparacion y utilizacion de la misma.
MX2010004974A (es) 2010-05-04 2011-11-23 Senosiain S A De C V Lab Combinacion de un aine y un aminoacido.
US8895622B2 (en) 2011-04-12 2014-11-25 Revogenex Ireland Ltd. Intravenous administration of tramadol
PT2636406E (pt) 2012-02-20 2015-11-20 Pharmaceutical Solutions Industry Ltd Perfusão intravenosa de ibuprofeno
ES2423866B1 (es) * 2012-02-22 2014-06-10 Farmalider, S.A. Composición farmaceútica de ibuprofeno y tramadol para inyección
ES2540151B1 (es) * 2013-10-11 2016-02-29 Farmalider S.A. Composición farmacéutica de ibuprofeno y tramadol para uso oftálmico
CN106413717A (zh) * 2014-04-10 2017-02-15 查尔斯顿实验室公司 药物组合物

Also Published As

Publication number Publication date
HUE062529T2 (hu) 2023-11-28
US12514833B2 (en) 2026-01-06
AU2020309160B2 (en) 2025-06-26
CA3145632C (en) 2024-03-12
MY207573A (en) 2025-03-05
BR112022000242A2 (pt) 2022-05-31
JP2022540854A (ja) 2022-09-20
JP7656339B2 (ja) 2025-04-03
HRP20230677T1 (hr) 2023-10-13
ES2952013T3 (es) 2023-10-26
MX2022000373A (es) 2022-02-10
FI3996699T3 (fi) 2023-08-01
RS64500B1 (sr) 2023-09-29
EP3996699B1 (en) 2023-06-28
AU2020309160A1 (en) 2022-02-17
MD3996699T2 (ro) 2023-11-30
DK3996699T3 (da) 2023-07-24
CA3145632A1 (en) 2021-01-14
US20220249414A1 (en) 2022-08-11
CN114080221A (zh) 2022-02-22
WO2021005129A1 (en) 2021-01-14
MA56341B1 (fr) 2023-07-31
SI3996699T1 (sl) 2023-10-30
CN114080221B (zh) 2023-12-05
PL3996699T3 (pl) 2023-10-30
EP3996699A1 (en) 2022-05-18

Similar Documents

Publication Publication Date Title
EP3836865C0 (en) ROBOT-ASSISTED MOVEMENTS OF ELONGATED MEDICAL DEVICES
EP3875150C0 (en) HIFU SKIN CARE DEVICE AND CARTRIDGE
PT3717471T (pt) Novos compostos e composições farmacêuticas dos mesmos para o tratamento de doenças
EP3920763A4 (en) SKIN CARE DEVICES
EP3565812C0 (en) TUBULIN-BINDING COMPOUNDS AND THEIR THERAPEUTIC USE
PT3600309T (pt) Combinações terapêuticas para o tratamento de doenças hepáticas
IL283968A (en) Benzamides of pyrazolyl-amino-pyrimidinyl derivatives, and compositions and methods thereof
BR112017025426A2 (pt) dispositivo para tratamento da pele e conjunto de cabeça de eletrodo
IL280001A (en) Device for facilitating the formation of new bone tissue
PT2582366E (pt) Combinação terapêutica para o tratamento da dor
PT2862565T (pt) Composição farmacêutica de ibuprofeno e tramadol para utilização oftalmológica
EP3565549A4 (en) SELECTIVE HISTONE DEACETYLASE INHIBITORS FOR THE TREATMENT OF HUMAN DISEASE
EP3405131A4 (en) BONE PLATE WITH A CONNECTOR AND CONNECTOR FOR A SURGICAL SLING
HRP20260206T1 (hr) Lakozamidni farmaceutski pripravak i njegov farmaceutski preparat
DK3452475T3 (da) Tetrahydropyridodiazepinforbindelser til at behandle smerte og smerterelaterede tilstande
EP3889138C0 (en) HISTONE ACETYLASE P300 INHIBITOR AND USE THEREOF
IL280150A (en) Graphene product and therapeutic uses thereof
PL3614990T3 (pl) Głowica masująca i urządzenie do masażu wykorzystujące taką głowicę
EP3914218C0 (en) ORTHOPEDIC DEVICE FOR MOBILIZING BALL JOINTS
IL281513A (en) Pharmaceutical compositions suitable for articular delivery and use thereof in treatment of joint pain
BR112017000359A2 (pt) combinação de pregabalina e meloxicam para o tratamento de dor neuropática
EP3522891A4 (en) PHARMACEUTICAL COMBINATIONS OF HISTONE DEACETYLASE INHIBITOR AND PROTEASOME INHIBITOR OR IMMUNOMODULATOR FOR THE TREATMENT OF HEMATOLOGICAL CANCER
MA42552A (fr) Compositions pharmaceutiques de flurbiprofène et de tramadol
PL3996699T3 (pl) Kombinacja ibuprofenu i tramadolu do uśmierzania bólu
DK3505218T3 (da) Mild rensemiddelsammensætning til fedtet og acneisk hud